StonvexLoading…
StonvexStonvexStonvexCore line items from INDI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $55.46M | $217.39M | $159.39M | $105.71M |
Operating Income | $-38.87M | $-154.22M | $-120.27M | $-81.93M |
Net Income | $-43.19M | $-143.07M | $-111.87M | $-73.58M |
EPS (Diluted) | $-0.21 | $-0.73 | $-0.57 | $-0.38 |
Total Assets | $869.56M | $840.79M | $855.07M | $867.63M |
Total Liabilities | $520.61M | $456.77M | $462.15M | $452.53M |
Cash & Equivalents | $174.43M | $145.46M | $160.87M | $192.56M |
Free Cash Flow OCF − CapEx | $-25.34M | $-71.42M | $-55.33M | $-45.00M |
Shares Outstanding | 207.03M | 197.25M | 195.29M | 193.23M |